Pantoprazole is a highly effective option for gastric acid-related disorders

Drugs and Therapy Perspectives

Volumn 8, Issue 4, 1996, Pages 1-5

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

BACTERICIDAL ACTIVITY; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SCREENING; DUODENUM ULCER; GASTRODUODENAL ULCER; GASTROESOPHAGEAL REFLUX; HEADACHE; HELICOBACTER PYLORI; HUMAN; PRURITUS; SHORT SURVEY; STOMACH ULCER; VERTIGO;

EID: 0030017807     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-199608040-00001     Document Type: Short Survey

References (16)

1. 1. A Fitton L Wiseman 1996 Pantoprazole A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 51 3 460 82 1:CAS:528:DyaK28XitlOitbw%3D Fitton A, Wiseman L. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996 Mar; 51(3): 460–82
2. 2. CM Spencer D Faulds 1994 Lansoprazole A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders. Drugs 48 3 404 430 1:CAS:528:DyaK2cXmsVCrsbs%3D Spencer CM, Faulds D. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders. Drugs 1994; 48(3): 404–430
3. 3. MI Wilde D McTavish 1994 Omeprazole An update of its pharmacology and therapeutic use in acid-related disorders. Drugs 48 1 91 132 1:STN:280:DyaK2M%2FksV2ltw%3D%3D Wilde MI, McTavish D. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs 1994; 48(1): 91–132
4. 4. Pantoprazole launched in France. Scrip 1996 Apr 2; (2116): 19
5. 5. LZ Benet K Zech 1994 Pharmacokinetics — a relevant factor for the choice of a drug? Aliment Pharmacol Ther 8 l 25 32 8180291 Benet LZ, Zech K. Pharmacokinetics — a relevant factor for the choice of a drug? Aliment Pharmacol Ther 1994; 8 (Suppl.l): 25–32
6. 6. British National Formulary No. 31. London: The Pharmaceutical Press, 1996 Mar: 37–40, 556
7. 7. W Kromer 1995 Similarities and differences in the properties of substituted benzimidazoles: a comparison between pantoprazole and related compounds Digestion 56 443 454 8536813 10.1159/000201275 1:CAS:528:DyaK28XovV2i Kromer W. Similarities and differences in the properties of substituted benzimidazoles: a comparison between pantoprazole and related compounds. Digestion 1995; 56: 443–454
8. 8. J Hotz K Plein H Schönekäs 1995 Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer Scand J Gastroenterol 30 111 5 7732331 10.3109/00365529509093247 1:STN:280:DyaK2M3kvF2hug%3D%3D Hotz J, Plein K, Schönekäs H. Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. Scand J Gastroenterol 1995 Feb;30: 111–5
9. 9. L Witzel H Gütz W Hüttermann 1995 Pantoprazole versus omeprazole in the treatment of acute gastric ulcers Aliment Pharmacol Ther 9 19 24 7766739 10.1111/j.1365-2036.1995.tb00346.x 1:STN:280:DyaK2M3osVWqug%3D%3D Witzel L, Gütz H, Hüttermann W, et al. Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. Aliment Pharmacol Ther 1995 Feb; 9: 19–24
10. 10. Hahn EG, Dammann HG, Adler G, et al. Pantoprazole provides faster healing and pain relief than famotidine in acute duodenal ulcer disease. Gastroenterology. In press.
11. 11. H Koop W Schepp HG Dammann 1995 Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis: results of a German multicenter study J Clin Gastroenterol 20 192 5 7797824 10.1097/00004836-199504000-00005 1:STN:280:DyaK2MzhvVCgtg%3D%3D Koop H, Schepp W, Dammann HG, et al. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis: results of a German multicenter study. J Clin Gastroenterol 1995 Apr; 20: 192–5
12. 12. Dammann HG, Hahn EG, Adler G, et al. Pantoprazole is more effective than famotidine in acute gastro-esophageal reflux disease. Gastroenterology. In press.
13. 13. G Brunner U Harke 1994 Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment Aliment Pharmacol Ther 8 59 64 8180296 Brunner G, Harke U. Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. Aliment Pharmacol Ther 1994; 8 Suppl. 1: 59–64
14. 14. Bardhan KD, Cherian P, Polak JM, et al. Pantoprazole (PANTO) in aggressive or refractory acid-peptic disease. Gastroenterology. In press.
15. 15. S Suerbaum H Leying K Klemm 1991 Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori Eur J Clin Microbiol Infect Dis 10 92 3 1864281 10.1007/BF01964416 1:CAS:528:DyaK38XjsVag Suerbaum S, Leying H, Klemm K, et al. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991 Feb; 10: 92–3
16. 16. Scholten T, Adler G, Bosseckert H, et al. Clinical tolerability of pantoprazole compared to H 2-antagonists: results of the German pantoprazole phase IV program. Gastroenterology. In press